Gokhan Yilmaz

Prof. Dr. Gokhan Yilmaz

CUNY School of Medicine, New York, USA
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2006 in Circulation
Verified
Journal Article
Closed access
GYGokhan Yilmaz
Gokhan Yilmaz
TAThiruma V. Arumugam
Thiruma V. Arumugam
KSKaren Y. Stokes
Karen Y. Stokes
DGD. Neil Granger
D. Neil Granger
Background—Although lymphocyte recruitment and activation are associated with cerebral ischemia-reperfusion (I/R) injury, the contributions of specific lymphocyte subpopulations and lymphocyte-derived interferon-γ (IFN-γ) to stroke remain unknown. The objectives of this study were to define the contribution of specific populations of lymphocytes to the inflammatory and prothrombogenic responses elicited in the cerebral microvasculature by I/R and to investigate the role of T-cell–associated IFN-γ in the pathogenesis of ischemic stroke.Methods and Results—Middle cerebral artery occlusion was induced for 1 hour (followed by 4 or 24 hours of reperfusion) in wild-type mice and mice deficient in lymphocytes (Rag1−/−), CD4+T cells, CD8+T cells, B cells, or IFN-γ. Platelet and leukocyte adhesion was assessed in cortical venules with intravital video microscopy. Neurological deficit and infarct volume were determined 24 hours after reperfusion. Rag1−/−, CD4+T-cell−/−, CD8+T-cell−/−, and IFN-γ−/−mice exhibited comparable significant reductions in I/R-induced leukocyte and platelet adhesion compared with wild-type mice exposed to I/R. Infarct volume was reduced and I/R-induced neurological deficit was improved in immunodeficient Rag1−/−mice. These protective responses were reversed in Rag1−/−mice reconstituted with either wild-type or, to a lesser extent, IFN-γ−/−splenocytes. B-cell–deficient mice failed to show improvement against ischemic stroke injury.Conclusions—These findings indicate that CD4+and CD8+T lymphocytes, but not B lymphocytes, contribute to the inflammatory and thrombogenic responses, brain injury, and neurological deficit associated with experimental stroke. Although IFN-γ plays a pivotal role in stroke-induced inflammatory responses, T lymphocytes appear to be a minor source of this cytokine.

5 July 2009 in NeuroMolecular Medicine
Verified
Journal Article
Closed access
PDF file
GYGokhan Yilmaz
Gokhan Yilmaz
DGD. Neil Granger
D. Neil Granger

1 October 2008 in Neurological Research
Verified
Journal Article
Closed access
GYGokhan Yilmaz
Gokhan Yilmaz
DGD. Neil Granger
D. Neil Granger
Objective: To describe the role of adhesion molecules in ischemic stroke. Methods: A PubMed search of literature pertaining to this study was conducted in April 2008 using specific keyword search terms pertaining to stroke and various listed subtopics related to adhesion molecules. Results: An important contribution of β2-integrins (CD11/CD18), intercellular adhesion molecule and P-selectin in the recruitment of leukocytes as well as platelets in the post-ischemic cerebral microvasculature has been defined in related studies. Immunoblockade or genetic deletion of these adhesion molecules has been shown to reduce infarct volume, edema, behavioral deficits and/or mortality in different animal models of ischemic stroke. Anti-adhesion agents also appear to widen the therapeutic window for thrombolytic therapy in these experimental models. An emerging role of inflammatory signaling pathways has also been addressed in modulating adhesion properties of post-ischemic cerebral microvasculature. Despite the promising data obtained from animal studies, few clinical trials assessing anti-adhesion therapy in ischemic stroke have failed to show efficacy. Discussion: Several experiments using cell surface adhesion molecules as targets of stroke therapy are promising yet inadequate. Clinical trials using immune blockade of adhesion molecules by antibodies have failed due to immune reactions of the host. Further clinical trials are needed to test the efficacy of humanized antibodies or non-immunogenic agents that interfere with cell adhesion mechanisms. Adhesion blocking strategies seem to be effective particularly at reperfusion and use of these strategies with thrombolytic therapies justifies a continued effort to define the role of adhesion molecules in the pathophysiology of cerebral ischemia–reperfusion.

7 May 2006 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
TAThiruma V Arumugam
Thiruma V Arumugam
SCSic L Chan
Sic L Chan
Dong-Gyu JoDong-Gyu Jo
Dong-Gyu Jo
GYGokhan Yilmaz
Gokhan Yilmaz
STSung-Chun Tang
Sung-Chun Tang
MMMark P Mattson
Mark P Mattson

1 September 2008 in Stroke
Verified
Journal Article
Closed access
PDF file
STSatoshi Terao
Satoshi Terao
GYGokhan Yilmaz
Gokhan Yilmaz
KSKaren Y. Stokes
Karen Y. Stokes
JRJanice Russell
Janice Russell
MIMami Ishikawa
Mami Ishikawa
DGD. Neil Granger
D. Neil Granger
Background and Purpose— Although chemokines have been implicated in cardiovascular diseases, few studies have addressed the role of these inflammatory mediators in ischemic stroke. This study tested the hypothesis that RANTES (CCL5; regulated on activation, normal T-cell expressed and secreted) mediates the cerebral microvascular dysfunction, inflammation, and tissue injury induced by brain ischemia and reperfusion. Methods— After 60-minute middle cerebral artery occlusion and reperfusion, the adhesion of leukocytes and platelets in cerebral venules, infarct volume, and blood–brain barrier permeability were measured in wild-type mice (WT), RANTES-deficient mice (RANTES −/− ), WT mice transplanted with RANTES −/− bone marrow (RANTES>WT), and control bone marrow chimeras (WT>WT). The concentration of RANTES and several cytokines was also measured by enzyme-linked immunosorbent assay and a cytometric bead array. Results— The enhanced leukocyte and platelet adhesion, increased blood–brain barrier permeability, and tissue infarction elicited in WT and WT>WT mice after middle cerebral artery occlusion and reperfusion were significantly blunted in RANTES −/− mice. Similar attenuation of the middle cerebral artery occlusion and reperfusion-induced responses were noted in RANTES>WT chimeras. Although RANTES deficiency did not alter the changes in tissue cytokine levels elicited by middle cerebral artery occlusion and reperfusion, plasma concentrations interleukin-6, interleukin-10, and interleukin-12 were all reduced. Conclusions— These findings implicate blood cell-derived RANTES in the microvascular, inflammatory, and tissue injury responses of the brain to ischemia and reperfusion.

5 April 2005 in Circulation
Verified
Journal Article
Closed access
PDF file
MIMami Ishikawa
Mami Ishikawa
TVThorsten Vowinkel
Thorsten Vowinkel
KSKaren Y. Stokes
Karen Y. Stokes
TAThiruma V. Arumugam
Thiruma V. Arumugam
GYGokhan Yilmaz
Gokhan Yilmaz
DGD. Neil Granger
D. Neil Granger
Background— CD40/CD40 ligand (CD40L) signaling contributes to proinflammatory and prothrombogenic responses in the vasculature. CD40/CD40L expression is elevated in patients after a transient ischemic attack or stroke. The purpose of this study was to investigate the role of CD40/CD40L signaling in cerebral microvascular dysfunction and tissue injury response to middle cerebral artery occlusion (MCAO) and reperfusion. Methods and Results— Intravital fluorescence microscopy was used to visualize the cerebral microcirculation of wild-type (WT), CD40-deficient, and CD40L-deficient mice subjected to 1-hour MCAO and 4-hour reperfusion. The adhesion of platelets and of leukocytes and vascular permeability were measured in postcapillary venules after 4-hour and 1-hour reperfusions, respectively. Cerebral infarct volume was analyzed 24 hours after reperfusion. Platelet and leukocyte adhesion was elevated and blood/brain barrier function was compromised by MCAO in WT mice. Blood cell recruitment and increased permeability were blunted in both CD40-deficient and CD40L-deficient mice. Infarct volume was also reduced in CD40- and CD40L-deficient mice compared with WT mice. Conclusions— Our findings indicate that CD40/CD40L signaling contributes to inflammatory and prothrombogenic responses and brain infarction induced by MCAO and reperfusion. The CD40/CD40L dyad may play a significant pathogenic role in the acute phase of ischemic stroke.